Introduction
Several percutaneous ventricular assist devices (pVADs) have become clinically available for cardiac support either in cardiogenic shock or, prophylactically, for percutaneous coronay interventions (PCIs) in patients at high-risk of haemodynamic deterioration
Summary
Percutaneous left ventricular assist devices (pVADs) can provide temporary circulatory support during high-risk percutaneous coronary interventions (PCIs). We describe the first case in Switzerland of high-risk PCI with a new pVAD, the HeartMate PHP axial pump (St Jude Medical).
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Case report
An otherwise active and independent 86-year-old male with a history of poorly controlled hypertension con- After the patient had given written informed consent, the decision to perform a HeartMate-PHP-assisted PCI was made. Both groins were used for vascular access. Clinical evidence in the years to come should provide the necessary data to identify the needs, risks and benefits associated with these devices.
